Skip to main content
Fig. 4 | Cardiovascular Diabetology

Fig. 4

From: Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes

Fig. 4

Myocardial remodeling, but not oxidative stress is improved with empagliflozin. a WGA staining for determination of myocyte cross sectional area (CSA), magnification ×40, b Picrosirius red staining for determination of interstitial fibrosis. Magnification ×5, inset ×40 and c 3-nitrotyrosine immunostaining for determination of oxidative stress. Magnification ×40, inset ×40. *P < 0.05 vs CkC and †P < 0.05 vs DbC. AGSI average grey scale intensities. All scale bars 50 μm

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840